Zacks Investment Research downgraded Herbalife Ltd. (NYSE:HLF) to Hold in a report released today.
- Updated: October 9, 2016
Zacks Investment Research has downgraded Herbalife Ltd. (NYSE:HLF) to Hold in a report released on 10/05/2016.
Previously on 9/22/2016, Zacks Investment Research released a statement about Herbalife Ltd. (NYSE:HLF) increased the target price from $0.00 to $68.00. At the time, this indicated a possible upside of 0.12%.
Just yesterday Herbalife Ltd. (NYSE:HLF) traded 0.11% higher at $63.47. Herbalife Ltd.’s 50-day moving average is $61.94 and its 200-day moving average is $61.57. The last stock price is up 3.12% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 680,089 shares of HLF traded hands, down from an average trading volume of 2,139,510
Recent Performance Chart
Herbalife Ltd. has 52 week low of $42.26 and a 52 week high of $72.22 with a PE ratio of 21.76 and has a market capitalization of $0.
Brief Synopsis On Herbalife Ltd. (NYSE:HLF)
Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. The Company's segments include North America; Mexico; South & Central America; Europe, Middle East, and Africa (EMEA); Asia Pacific, and China. The Company markets and sells over 140 products, encompassing approximately 5,000 stock keeping units (SKUs) globally. Its product categories include Weight Management; Targeted Nutrition; Energy, Sports and Fitness; Outer Nutrition, and Literature, Promotional and Other. The Company's representative products include Formula 1 Healthy Meal, Herbal Tea Concentrate, Protein Drink Mix, Personalized Protein Powder, Total Control, Prolessa Duo, Protein Bars, Aloe Concentrate, Niteworks, Garden 7 phytonutrient supplement, Best Defense for improved immune system, COQ10 Plus and Herbalife SKIN line.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.